Sign in Subscribe
Drugs

Researchers Investigate Snake and Scorpion Venom as Potential AIDS Medications

Strategic Insights

— 1 min read

Researchers at an international AIDS meeting are exploring the use of snake and scorpion venom as novel medications to combat the global AIDS epidemic. The studies, while promising, have sparked skepticism among some experts, highlighting the desperation to find new treatments as the virus becomes increasingly resistant to mainline therapies.

Key Takeaways:

  • Researchers are investigating compounds developed from the venom of snakes and scorpions, which have shown preliminary effectiveness against HIV in studies.
  • The venom compounds may have properties that can modulate the immune system and potentially lead to the development of genetically-engineered drugs.
  • Bristol-Myers Squibb's executive director of HIV clinical research, Dr. Lisa Dunkle, notes that the goal is to find a drug that can overcome resistance to AZT, the main drug used to prevent the development of AIDS.
  • Dunkle presented data on her company's drug stavudine (d4T), which was significantly superior to AZT in preventing AIDS infections, immune system destruction, and death.
  • The scorpion venom study found that the venom created mutations in HIV that could have useful therapeutic properties.
  • The researchers are cautious not to imply endorsement of the studies, but rather to promote scientific inquiry and openness to novel approaches.
  • Dunkle expressed the willingness among scientists to try any path in fighting AIDS, highlighting the desperation to find an answer for this disease.

Statistics:

  • 6 people with AIDS participated in a study of Solutein, a compound developed from the venom of three snakes, and showed immune system modulating effects.
  • Stavudine (d4T) was shown to be significantly superior to AZT in preventing AIDS infections, immune system destruction, and death.
  • AZT reduces the risk of HIV transmission to the babies of infected pregnant women by about 2/3.
  • A small pilot study of Vesnarinone, a drug used for heart failure, found that the drug was well-tolerated by AIDS patients and seemed to have properties that helped stimulate the patients' immune system.
  • 12 patients completed the course of treatment with Vesnarinone, and no disease progression was seen.

Sources:

  • ED SUSMAN, "Researchers Investigate Snake and Scorpion Venom as Novel AIDS Medications," United Press International, September 28
  • Dr. Lisa Dunkle, executive director of HIV clinical research for Bristol-Myers Squibb
  • Edward King, editor of AIDS Treatment Update

Read more